Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2016 07:00 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition

ROCKVILLE, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today provided additional detail regarding its...
March 09, 2015 02:40 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo to Return All Licenses for Unoprostone Isopropyl to R-Tech Ueno

BETHESDA, Md., March 9, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced it will immediately return all licenses for...
February 11, 2015 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R)

BETHESDA, Md., Feb. 11, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo and R-Tech Ueno, Ltd. (RTU),...
August 21, 2014 16:30 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for Lubiprostone

BETHESDA, Md., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that its subsidiary, Sucampo AG, has signed...